Survival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance
Authors:
- 1 January 2018
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 14 (1) , e59-e72
Abstract
Purpose: Survival is considered an important indicator of the quality of cancer care, but the validity of different methodologies to measure comparative survival rates is less well understood. We explored whether the National Cancer Data Base (NCDB) could serve as a source of unadjusted and risk-adjusted cancer survival data and whether these data could be used as quality indicators for individual hospitals or in the aggregate by hospital type. Methods: The NCDB, an aggregate of > 1,500 hospital cancer registries, was queried to analyze unadjusted and risk-adjusted hazards of death for patients with stage III breast cancer (n = 116,787) and stage IIIB or IV non–small-cell lung cancer (n = 252,392). Data were analyzed at the individual hospital level and by hospital type. Results: At the hospital level, after risk adjustment, few hospitals had comparative risk-adjusted survival rates that were statistically better or worse. By hospital type, National Cancer Institute–designated comprehensive cancer centers had risk-adjusted survival ratios that were statistically significantly better than those of academic cancer centers and community hospitals. Conclusion: Using the NCDB as the data source, survival rates for patients with stage III breast cancer and stage IIIB or IV non–small-cell lung cancer were statistically better at National Cancer Institute–designated comprehensive cancer centers when compared with other hospital types. Compared with academic hospitals, risk-adjusted survival was lower in community hospitals. At the individual hospital level, after risk adjustment, few hospitals were shown to have statistically better or worse survival, suggesting that, using NCDB data, survival may not be a good metric to determine relative quality of cancer care at this level.Keywords
This publication has 15 references indexed in Scilit:
- England's 30-day chemotherapy mortality: a measure of quality of care?The Lancet Oncology, 2016
- 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational studyThe Lancet Oncology, 2016
- Do cancer survival statistics for every hospital make sense?The Lancet Oncology, 2016
- Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer StageJAMA Oncology, 2015
- Development and Future of the American Society of Clinical Oncology's Quality Oncology Practice InitiativeJournal of Clinical Oncology, 2014
- Delivering High-Quality Cancer Care2013
- What Is Value in Health Care?New England Journal of Medicine, 2010
- Partnering With Payers for Success: Quality Oncology Practice Initiative, Blue Cross Blue Shield of Michigan, and the Michigan Oncology Quality ConsortiumJournal of Oncology Practice, 2009
- Improvement in Oncology Practice Performance Through Voluntary Participation in the Quality Oncology Practice InitiativeJournal of Clinical Oncology, 2008
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004